2012
DOI: 10.1128/aac.00539-12
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of Poliovirus Variants Selected for Resistance to the Antiviral Compound V-073

Abstract: 93). The resistance phenotype was relatively stable upon passage of viruses in cell culture in the absence of drug. Single-step growth studies showed no substantial differences between drug-resistant variants and the virus stocks from which they were derived, while the resistant viruses were generally more thermally labile than the corresponding drug-susceptible parental viruses. These studies provide a foundation from which to build a greater understanding of resistance to antiviral compound V-073.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
21
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(23 citation statements)
references
References 16 publications
2
21
0
Order By: Relevance
“…However, populations of this very sensitive virus always contain tiny proportions (depending on the drug concentration tested) of guanidine-resistant (g r ) mutants (61), or even mutants whose growth requires the presence of this drug (62; also see below). The presence of drug-resistant and drug-dependent variants in largely sensitive populations has also been reported for other picornaviruses and other inhibitors (63)(64)(65)(66)(67)(68)(69)(70)(71). Different variants within heterogeneous viral populations may complement each other in performing some functions, as appears to be the case with poliovirus (10,14,22,32), although the converse situation, negative trans-dominance of debilitating mutations, has also been documented (72,73).…”
Section: Introductionmentioning
confidence: 80%
“…However, populations of this very sensitive virus always contain tiny proportions (depending on the drug concentration tested) of guanidine-resistant (g r ) mutants (61), or even mutants whose growth requires the presence of this drug (62; also see below). The presence of drug-resistant and drug-dependent variants in largely sensitive populations has also been reported for other picornaviruses and other inhibitors (63)(64)(65)(66)(67)(68)(69)(70)(71). Different variants within heterogeneous viral populations may complement each other in performing some functions, as appears to be the case with poliovirus (10,14,22,32), although the converse situation, negative trans-dominance of debilitating mutations, has also been documented (72,73).…”
Section: Introductionmentioning
confidence: 80%
“…As a candidate compound of capsid-binding inhibitors, the effectiveness of V-073 (previously designated SCH 48973) on in vitro PV infection and in a mouse infection model has been intensively analyzed in terms of the resistant mutation, pathogenicity of resistant mutants, and effects on immunization with IPV (28)(29)(30)(31)(32). To date, several enviroxime-like compounds have been identified, including TTP-8307 (33), some cellular protein kinase inhibitors (GW5074 and Flt3 inhibitor II) (34,35), and a bifunctional antienterovirus compound, AN-12-H5, which targets the replication process of PV and enterovirus 71 (EV71) and also an early stage of EV71 infection (36).…”
mentioning
confidence: 99%
“…This shows that the amino acid substitutions found in the variants offer little advantage or disadvantage for the variants, and that the variants will replicate to the same extent as the parental strain in the absence of the VHH. This also has been observed for other neutralization escape variants against poliovirus types 1, 2, and 3 (39,40).…”
Section: Discussionmentioning
confidence: 63%